Earendil Labs, an AI-driven biotechnology company advancing next-generation biologics, today announced the first patient has ...

Researchers have screened chemical compounds that are found in ginger to find those with relevant bioactivity. This work identified a ginger compound called furanodienone (FDN) that can attach to a ...

Merck & Co. will apply the somatic genomics platform Quotient Therapeutics to discover novel drug targets in inflammatory bowel disease (IBD), through a collaboration that could generate up to $2.2 ...

HC Wainwright upgraded Shattuck Labs Inc. (NASDAQ: STTK) from Neutral to Buy, with a price forecast of $6. The company’s lead product candidate, SL-325, is a DR3 antagonist antibody for inflammatory ...

Ace Therapeutics recently launched in vivo efficacy testing services for IBD drug candidates. Ace Therapeutics, a preclinical contract research provider, announced recently that it has launched in ...

WILMINGTON, Del., April 2, 2026 /PRNewswire/ -- Earendil Labs, an AI-driven biotechnology company advancing next-generation biologics, today announced the first patient has been dosed in a Phase IIa ...

– SL-325 is a potentially first-in-class DR3 antagonist antibody being developed for the treatment of Inflammatory Bowel Disease (IBD) and other inflammatory and immune-mediated diseases – – The ...

Neha Pathak, MD, FACP, DipABLM: Welcome to the WebMD Health Discovered Podcast. I'm Dr Neha Pathak, WebMD's Chief Physician Editor for Health and Lifestyle Medicine. Today we're going to discuss a ...

Inflammatory Bowel Disease (IBD) is a chronic disease of inflammation along the digestive tract. There are two forms of IBD, including Crohn’s disease and ulcerative colitis. Symptoms include ...

Advanced therapies are not linked to increased risk for serious or opportunistic infections, cancer, operations, or mortality among those with HIV and IBD.